This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bostwick DG et al. (2005) Epidemiology and statistical methods in prediction of patient outcome. Scand J Urol Nephrol 216 (Suppl): S94–S110
Thompson IM et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliter. New Engl J Med 350: 2239–2246
Stapleton AM and Pinnock CB (2005) Nomograms for prostate cancer—is their use evidence-based? Nat Clin Pract Urol 2: 462–463
Barry MJ (2005) Revisiting my personal decision about prostate-specific antigen testing in 2005. BJU Int 96: 954–956
Smith RA et al. (2006) American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56: 11–25
Acknowledgements
The synopsis was written by Carol Lovegrove, Freelance Medical Writer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Adolfsson, J. Individualized assessment of prostate cancer risk. Nat Rev Urol 3, 522–523 (2006). https://doi.org/10.1038/ncpuro0586
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0586